[18F]PSMA-1007 PET is comparable to [99mTc]Tc-DMSA SPECT for renal cortical imaging
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
[18F]PSMA-1007 PET is comparable to [99mTc]Tc-DMSA SPECT for renal cortical imaging ; volume:7 ; number:1 ; day:24 ; month:11 ; year:2023 ; pages:1-10 ; date:12.2023
European journal of hybrid imaging ; 7, Heft 1 (24.11.2023), 1-10, 12.2023
- Urheber
-
Valind, Kristian
Minarik, David
Garpered, Sabine
Persson, Eva
Jögi, Jonas
Trägårdh, Elin
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s41824-023-00185-2
- URN
-
urn:nbn:de:101:1-2024012211555278789034
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Valind, Kristian
- Minarik, David
- Garpered, Sabine
- Persson, Eva
- Jögi, Jonas
- Trägårdh, Elin
- SpringerLink (Online service)
Ähnliche Objekte (12)
![Diagnostic efficacy of [99mTc]Tc-PSMA SPECT/CT for prostate cancer: a meta-analysis](/assets/placeholder/searchResultMediaUnknown.png)
Diagnostic efficacy of [99mTc]Tc-PSMA SPECT/CT for prostate cancer: a meta-analysis
Tc-99m-PSMA-SPECT/CT Is Superior to Tc-99m-MDP-SPECT/CT in the Staging of Prostatic Cancer with Osseous Metastases after External Beam Radiotherapy
![Erythrozytenmarkierung mit 99mTc [Tc]](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
Erythrozytenmarkierung mit 99mTc [Tc]
The Theranostic Optimization of PSMA-GCK01 Does Not Compromise the Imaging Characteristics of [99mTc]Tc-PSMA-GCK01 Compared to Dedicated Diagnostic [99mTc]Tc-EDDA/HYNIC-iPSMA in Prostate Cancer
Real world experience with [99mTc]Tc-HYNIC-iPSMA SPECT prostate cancer detection: interim results from the global NOBLE registry
Head-to-head comparison of 99mTc-PSMA and 99mTc-MDP SPECT/CT in diagnosing prostate cancer bone metastasis: a prospective, comparative imaging trial
Automated synthesis and quality control of [99mTc]Tc-PSMA for radioguided surgery (in a [68Ga]Ga-PSMA workflow)
Plasmaclearance von 99mTc-Methylendiphosphonat [Neunundneunzig-m-Tc-Methylendiphosphonat], 99mTc-Tripolyphosphat [Neunundneunzig-m-Tc-Tripolyphosphat] und 99mTc-Tetrapolyphosphat [Neunundneunzig-m-Tc-Tetrapolyphosphat] in Beziehung zur Plasmaproteinbindung
Quantitative 99mTc-DPD-SPECT/CT assessment of cardiac amyloidosis
Optimization of SPECT/CT imaging protocols for quantitative and qualitative 99mTc SPECT
Tc-99m-DMPE/Dimethylphosphinoethan
Biotinmarkierung mit Tc-99m
Diagnostic efficacy of [99mTc]Tc-PSMA SPECT/CT for prostate cancer: a meta-analysis
Tc-99m-PSMA-SPECT/CT Is Superior to Tc-99m-MDP-SPECT/CT in the Staging of Prostatic Cancer with Osseous Metastases after External Beam Radiotherapy
Erythrozytenmarkierung mit 99mTc [Tc]
The Theranostic Optimization of PSMA-GCK01 Does Not Compromise the Imaging Characteristics of [99mTc]Tc-PSMA-GCK01 Compared to Dedicated Diagnostic [99mTc]Tc-EDDA/HYNIC-iPSMA in Prostate Cancer
Real world experience with [99mTc]Tc-HYNIC-iPSMA SPECT prostate cancer detection: interim results from the global NOBLE registry
Head-to-head comparison of 99mTc-PSMA and 99mTc-MDP SPECT/CT in diagnosing prostate cancer bone metastasis: a prospective, comparative imaging trial
Automated synthesis and quality control of [99mTc]Tc-PSMA for radioguided surgery (in a [68Ga]Ga-PSMA workflow)
Plasmaclearance von 99mTc-Methylendiphosphonat [Neunundneunzig-m-Tc-Methylendiphosphonat], 99mTc-Tripolyphosphat [Neunundneunzig-m-Tc-Tripolyphosphat] und 99mTc-Tetrapolyphosphat [Neunundneunzig-m-Tc-Tetrapolyphosphat] in Beziehung zur Plasmaproteinbindung
Quantitative 99mTc-DPD-SPECT/CT assessment of cardiac amyloidosis
Optimization of SPECT/CT imaging protocols for quantitative and qualitative 99mTc SPECT
Tc-99m-DMPE/Dimethylphosphinoethan
Biotinmarkierung mit Tc-99m
Diagnostic efficacy of [99mTc]Tc-PSMA SPECT/CT for prostate cancer: a meta-analysis
Tc-99m-PSMA-SPECT/CT Is Superior to Tc-99m-MDP-SPECT/CT in the Staging of Prostatic Cancer with Osseous Metastases after External Beam Radiotherapy
Erythrozytenmarkierung mit 99mTc [Tc]
The Theranostic Optimization of PSMA-GCK01 Does Not Compromise the Imaging Characteristics of [99mTc]Tc-PSMA-GCK01 Compared to Dedicated Diagnostic [99mTc]Tc-EDDA/HYNIC-iPSMA in Prostate Cancer
Real world experience with [99mTc]Tc-HYNIC-iPSMA SPECT prostate cancer detection: interim results from the global NOBLE registry
Head-to-head comparison of 99mTc-PSMA and 99mTc-MDP SPECT/CT in diagnosing prostate cancer bone metastasis: a prospective, comparative imaging trial
Automated synthesis and quality control of [99mTc]Tc-PSMA for radioguided surgery (in a [68Ga]Ga-PSMA workflow)
Plasmaclearance von 99mTc-Methylendiphosphonat [Neunundneunzig-m-Tc-Methylendiphosphonat], 99mTc-Tripolyphosphat [Neunundneunzig-m-Tc-Tripolyphosphat] und 99mTc-Tetrapolyphosphat [Neunundneunzig-m-Tc-Tetrapolyphosphat] in Beziehung zur Plasmaproteinbindung
Quantitative 99mTc-DPD-SPECT/CT assessment of cardiac amyloidosis
Optimization of SPECT/CT imaging protocols for quantitative and qualitative 99mTc SPECT
Tc-99m-DMPE/Dimethylphosphinoethan